Akari Therapeutics Plc - American Depositary Shares — Balance Sheet (NASDAQ:AKTX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 14.6 M11.65 M13.83 M4.36 M50.56 M Total liabilities 5.22 M6.09 M12.04 M4.58 M28.33 M Total equity 9.38 M5.55 M1.79 M229 K22.23 M Total liabilities & shareholders' equities 14.6 M11.65 M13.83 M4.36 M50.56 M Total debt ————— Net debt —————

Nachrichten

Akari Therapeutics verstärkt wissenschaftlichen Beirat mit RNA-Spleiß-Expertin

Akari Therapeutics adds RNA splicing expert to advisory board

Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aimei Health Technology (NASDAQ:AFJK)

Akari Therapeutics treibt Onkologie-Programm mit neuartigem ADC-Wirkstoff voran

Akari Therapeutics advances ADC oncology program with novel payload

Akari startet GMP-Produktion für führendes ADC-Programm mit WuXi XDC

Akari begins GMP manufacturing of lead ADC program with WuXi XDC

Akari Therapeutics beschafft 5 Millionen US-Dollar durch marktkonforme Emission

Akari Therapeutics raises $5 million in at-market offering

Vielversprechende Krebsdaten treiben Aktie von Akari Therapeutics an

Akari Therapeutics stock rises on promising pancreatic cancer drug data

Nasdaq-Verwarnung für Akari Therapeutics wegen Unterschreitung des Mindestkurses